News Conference News ESC 2025 AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC Todd Neale September 01, 2025
News Conference News ESC 2025 No Benefit to Routine CT Angiography After Left Main PCI: PULSE Michael O'Riordan August 31, 2025
News Conference News ESC 2024 More Support for Ticagrelor Monotherapy After PCI, Especially in ACS Yael L. Maxwell September 10, 2024
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Daily News ESC 2021 Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI Caitlin E. Cox August 26, 2021
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Conference News ESC 2017 Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI Shelley Wood September 01, 2017
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Conference News ESC 2014 ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration Yael L. Maxwell September 01, 2014